Restoring adiponectin via rosiglitazone ameliorates tissue wasting in mice with lung cancer

Rosiglitazone
DOI: 10.1111/apha.14167 Publication Date: 2024-05-23T08:40:14Z
ABSTRACT
To investigate systemic regulators of the cancer-associated cachexia syndrome (CACS) in a pre-clinical model for lung cancer with goal to identify therapeutic targets tissue wasting.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (53)
CITATIONS (2)